Preparing for Takeoff, the “Worthless” Coin, & Royal Investments
Over the course of three days, Southwest Airlines has canceled more than 2,000 flights and left thousands of travelers stranded around the country. CNBC’s Phil LeBeau and Casey Murray, president of th...
12 Loka 202124min
Southwest Stuck at the Gate; Biotech’s Breakthroughs: The Covid Pill
Merck and partner Ridgeback Biotherapeutics have asked the FDA to approve their Covid-19 antiviral pill molnupiravir for emergency use. It’s only the latest in a stream of biotech innovation this year...
11 Loka 202128min
Tinder & Lyft to Netflix & Chill; Debt Crisis Averted--For Now
The U.S. economy created much fewer jobs in September than economists were hoping, a disheartening sign of the country’s pandemic recovery. CNBC’s Steve Liesman, BlackRock’s Kate Moore, and Chicago Bo...
8 Loka 202129min
A Global Gas Crisis & a Battle-Tested Risk Theory
Global gas prices are soaring, and Americans are now paying the most at the pump in seven years. Jeffrey Currie, Goldman Sachs global head of commodities research, discusses what’s driving the spike i...
7 Loka 202124min
Facebook’s Whistleblower & DC’s Impending Deadline
Facebook faced negative testimony about user health and safety from a whistleblower yesterday in front of Congress. CNBC’s Julia Boorstin reports Facebook CEO Mark Zuckerberg is defending the company ...
6 Loka 202131min
Sec. Janet Yellen on Avoiding “Catastrophe,” & Michael Dell Tells All
As the debt ceiling deadline looms, Treasury Secretary Janet Yellen says a failure to suspend or raise it could mean “catastrophic” consequences for the U.S. economy and reputation. If Congress does n...
5 Loka 202136min
Ozy Media CEO Carlos Watson, On the Record
Ozy Media CEO Carlos Watson speaks out, addressing numerous reports of mistruths that have led to his company’s demise. Confronted with misleading claims in his own company’s pitch deck and a review o...
4 Loka 202133min
Merck’s Covid Pill; Ozy Media’s Meltdown; Facebook, Finsta, & Teenage Health
Merck and Ridgeback Biotherapeutics have developed a therapeutic pill for Covid that reduces the risk of hospitalization or death by around 50% for patients with mild or moderate cases. CNBC’s Meg Tir...
1 Loka 202130min
